Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 27:10:324.
doi: 10.3389/fimmu.2019.00324. eCollection 2019.

Application of Plasma Exchange in Steroid-Responsive Encephalopathy

Yuting Jiang  1 , Xin Tian  1 , Yixue Gu  1 , Feng Li  1 , Xuefeng Wang  1   2
Affiliations
Review

Application of Plasma Exchange in Steroid-Responsive Encephalopathy

Yuting Jiang et al. Front Immunol. .

Abstract

Plasma exchange has been widely used in autoimmune neurological diseases and is the standard treatment for myasthenia gravis crisis and Guillain-Barre syndrome. A growing body of research suggests that, in the clinical application of steroid-responsive encephalopathy, such as for Hashimoto's encephalopathy, limbic encephalitis, systemic lupus erythematosus encephalopathy, ANCA-associated vasculitis encephalopathy, and acute disseminated encephalomyelitis, plasma exchange is a safe, and effective option when steroids or other immunosuppressive therapies are ineffective in the short term or when contraindications are present. Additionally, plasma exchange can also be used alone or in combination with steroids, immunoglobulins, or other immunosuppressive agents to treat steroid-responsive encephalopathy. This paper reviews the clinical application of plasma exchange in steroid-responsive encephalopathy, including its indications, onset time, course, curative effects, and side effects.

Keywords: clinical practice; course; onset time; plasma exchange; side effects; steroid.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schwartz J. Evidence-based guideline update: plasmapheresis in neurologic disorders. Neurology. (2011) 77:e105–6; author reply: e6. 10.1212/WNL.0b013e318230b33f - DOI - PubMed
    1. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. . Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the seventh special issue. J Clin Apheresis. (2016) 31:149–62. 10.1002/jca.21470 - DOI - PubMed
    1. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, et al. . Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. (2006) 63:197–202. 10.1001/archneur.63.2.197 - DOI - PubMed
    1. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs. (2007) 21:799–811. 10.2165/00023210-200721100-00002 - DOI - PubMed
    1. Nagpal T, Pande S. Hashimoto's encephalopathy: response to plasma exchange. Neurol. India. (2004) 52:245–7. - PubMed

Publication types